Partner Therapeutics, Inc. is a Massachusetts-based biopharmaceutical company. It lobbies Congress on health-related issues, especially laws and funding tied to developing medical countermeasures for public health emergencies and the reauthorization of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act. It has reported five filings totaling $320,000 and has hired the CGCN Group to represent it.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JILL HAMAKER
The latest disclosures for this client.
CGCN GROUP, LLC
Q1CGCN GROUP, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CGCN GROUP, LLC
TRAVIS CONE
CGCN GROUP, LLC
mrs MARTHA BEATRICE MILLER
CGCN GROUP, LLC
CGCN GROUP, LLC
Q3CGCN GROUP, LLC
Q2CGCN GROUP, LLC
Q1CGCN GROUP, LLC
RR